Wealthspire Advisors (New York)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.69M Sell
58,162
-982
-2% -$45.5K 0.02% 236
2025
Q1
$3.61M Buy
59,144
+30,465
+106% +$1.86M 0.02% 186
2024
Q4
$1.62M Buy
28,679
+170
+0.6% +$9.62K 0.02% 278
2024
Q3
$1.48M Buy
28,509
+1,286
+5% +$66.5K 0.02% 301
2024
Q2
$1.13M Sell
27,223
-1,464
-5% -$60.8K 0.01% 299
2024
Q1
$1.56M Sell
28,687
-6,714
-19% -$364K 0.02% 240
2023
Q4
$1.82M Buy
35,401
+5,962
+20% +$306K 0.03% 211
2023
Q3
$1.71M Buy
29,439
+4,878
+20% +$283K 0.03% 189
2023
Q2
$1.57M Sell
24,561
-2,522
-9% -$161K 0.03% 177
2023
Q1
$1.88M Sell
27,083
-4,398
-14% -$305K 0.03% 162
2022
Q4
$2.27M Buy
31,481
+3,621
+13% +$261K 0.04% 140
2022
Q3
$1.98M Buy
27,860
+5,123
+23% +$364K 0.04% 144
2022
Q2
$1.75M Buy
22,737
+4,833
+27% +$372K 0.04% 154
2022
Q1
$1.31M Sell
17,904
-6,067
-25% -$443K 0.03% 165
2021
Q4
$1.5M Buy
23,971
+1,765
+8% +$110K 0.03% 175
2021
Q3
$1.31M Buy
22,206
+16,152
+267% +$956K 0.03% 214
2021
Q2
$405K Sell
6,054
-34,236
-85% -$2.29M 0.01% 251
2021
Q1
$2.54M Buy
40,290
+8,700
+28% +$549K 0.06% 148
2020
Q4
$1.96M Buy
31,590
+10,089
+47% +$626K 0.06% 140
2020
Q3
$1.3M Buy
21,501
+3,611
+20% +$218K 0.08% 107
2020
Q2
$1.05M Sell
17,890
-18,515
-51% -$1.09M 0.07% 102
2020
Q1
$2.03M Buy
36,405
+27,128
+292% +$1.51M 0.09% 121
2019
Q4
$595K Buy
9,277
+4,360
+89% +$280K 0.04% 92
2019
Q3
$249K Buy
+4,917
New +$249K 0.02% 135
2019
Q1
Sell
-1,064
Closed -$55K 146
2018
Q4
$55K Buy
+1,064
New +$55K 0.01% 170